Module

Novel Antiretroviral Agents

Source: HIV/AIDS Annual Update 2008

Novel Antiretroviral Agents

Faculty:
Joseph J. Eron, Jr., MD

CME CREDIT INFORMATION

Release Date: 05/21/08

Expiration Date: 05/20/09

Physicians: maximum of 1.25 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.4 contact hours (0.14 CEUs)

Registered Nurses: 1.4 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the mechanisms of action of newly approved agents from novel classes
Recount the safety and efficacy of new agents from novel classes
Summarize the safety and efficacy of the novel NNRTI etravirine
Discuss the application of newly approved agents in clinical practice to improve rates of virologic suppression in treatment-experienced patients

Topics covered include:

Introduction
New Agents in Existing Classes: NNRTIs
New Agents in Novel Classes: Entry Inhibitors
New Agents in Novel Classes: Integrase Inhibitors
New Agents in Novel Classes: Maturation Inhibitors
Clinical Strategies for Using New Agents
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.